Top compounds associated with response to RAPGEF4

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	masitinib	GDSC1000	pan-cancer	AAC	0.059	0.07
mRNA	Methotrexate	FIMM	pan-cancer	AAC	-0.23	0.07
mRNA	navitoclax:birinapant (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.066	0.07
mRNA	thalidomide	CTRPv2	pan-cancer	AAC	0.099	0.08
mRNA	Bax channel blocker	CTRPv2	pan-cancer	AAC	0.068	0.08
mRNA	AM-580	CTRPv2	pan-cancer	AAC	-0.066	0.08
mRNA	BRD8958	CTRPv2	pan-cancer	AAC	0.071	0.08
mRNA	BRD-K27188169:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.092	0.08
mRNA	AKT inhibitor VIII	GDSC1000	pan-cancer	AAC	-0.062	0.08
mRNA	Merck60	CTRPv2	pan-cancer	AAC	-0.054	0.08

Download CSV